Re-thinking the Etiological Framework of Neurodegeneration
Open accessThe DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases are among the leading causes of disability and death worldwide. The disease-related socioeconomic burden is expected to increase with the steadily increasing life expectancy. In spite of decades of clinical and basic research, most strategies designed to manage degenerative brain diseases are palliative. This is not surprising as neurodegeneration progresses "silently" for decades before symptoms are noticed. Importantly, conceptual models with heuristic value used to study neurodegeneration have been constructed retrospectively, based on signs and symptoms already present in affected patients; a circumstance that may confound causes and consequences. Hence, innovative, paradigm-shifting views of the etiology of these diseases are necessary to enable their timely prevention and treatment. Here, we outline four alternative views, not mutually exclusive, on different etiological paths toward neurodegeneration. First, we propose neurodegeneration as being a secondary outcome of a primary cardiovascular cause with vascular pathology disrupting the vital homeostatic interactions between the vasculature and the brain, resulting in cognitive impairment, dementia, and cerebrovascular events such as stroke. Second, we suggest that the persistence of senescent cells in neuronal circuits may favor, together with systemic metabolic diseases, neurodegeneration to occur. Third, we argue that neurodegeneration may start in response to altered body and brain trophic interactions established via the hardwire that connects peripheral targets with central neuronal structures or by means of extracellular vesicle (EV)-mediated communication. Lastly, we elaborate on how lifespan body dysbiosis may be linked to the origin of neurodegeneration. We highlight the existence of bacterial products that modulate the gut-brain axis causing neuroinflammation and neuronal dysfunction. As a concluding section, we end by recommending research avenues to investigate these etiological paths in the future. We think that this requires an integrated, interdisciplinary conceptual research approach based on the investigation of the multimodal aspects of physiology and pathophysiology. It involves utilizing proper conceptual models, experimental animal units, and identifying currently unused opportunities derived from human data. Overall, the proposed etiological paths and experimental recommendations will be important guidelines for future cross-discipline research to overcome the translational roadblock and to develop causative treatments for neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Nitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
Research works printed but not linked: 213
- Andrade, 2014, The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms., Circ. Res., 114, 1453, 10.1161/circresaha.114.303211 · DOI · Paper page
- Anselmino, 2016, Transient cerebral hypoperfusion and hypertensive events during atrial fibrillation: a plausible mechanism for cognitive impairment., Sci. Rep., 6, 10.1038/srep28635 · DOI
- Arai, 1991, Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer’s disease and control subjects., Ann. Neurol., 30, 686, 10.1002/ana.410300509 · DOI · Paper page
- Ashley, 2018, Retrovirus-like gag protein arc1 binds RNA and traffics across synaptic boutons., Cell, 172, 262, 10.1016/j.cell.2017.12.022 · DOI · Paper page
- Ask, 2018, The neuro-immuno-senescence integrative model (NISIM) on the negative association between parasympathetic activity and cellular senescence., Front. Neurosci., 12, 10.3389/fnins.2018.00726 · DOI
- Avila-Nava, 2017, Food combination based on a pre-hispanic Mexican diet decreases metabolic and cognitive abnormalities and gut microbiota dysbiosis caused by a sucrose-enriched high-fat diet in rats., Mol. Nutr. Food Res., 61, 10.1002/mntr.201501023 · doi:10.1002/mntr.201501023
- Balusu, 2016, Identification of a novel mechanism of blood-brain communication during peripheral inflammation via choroid plexus-derived extracellular vesicles., EMBO Mol. Med., 8, 1162, 10.15252/emmm.201606271 · DOI · Paper page
- Banerjee, 2017, Stroke caused by atherosclerosis of the major intracranial arteries., Circ. Res., 120, 502, 10.1161/circresaha.116.308441 · DOI · Paper page
- Baothman, 2016, The role of gut microbiota in the development of obesity and diabetes., Lipids Health Dis., 15, 10.1186/s12944-016-0278-4 · DOI · Paper page
- Bhattacharjee, 2013, Alzheimer’s disease and the microbiome., Front. Cell Neurosci., 7, 10.3389/fncel.2013.00153 · DOI · Paper page
- Bilgel, 2019, Predicting time to dementia using a quantitative template of disease progression., Alzheimers Dement, 11, 205, 10.1016/j.dadm.2019.01.005 · DOI · Paper page
- Bloemen, 2010, Short chain fatty acids exchange: is the cirrhotic, dysfunctional liver still able to clear them?, Clin. Nutr., 29, 365, 10.1016/j.clnu.2009.10.002 · DOI
- Blum-Degen, 1995, Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?, J. Neural Transm. Suppl., 46, 139
- Bohnen, 2011, White matter lesions in Parkinson disease., Nat Rev Neurol, 7, 229, 10.1038/nrneurol.2011.21 · DOI · Paper page
- Braak, Staging of brain pathology related to sporadic Parkinson’s disease., Neurobiol. Aging, 24, 197, 10.1016/s0197-4580(02)00065-9 · DOI · Paper page
- Braak, Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen., J. Neural Transm., 110, 517, 10.1007/s00702-002-0808-2 · DOI · Paper page
- Broadwell, 1989, Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal., Acta Neuropathol., 79, 117, 10.1007/bf00294368 · DOI · Paper page
- Brouns, 2011, Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome., Eur. Neurol., 65, 23, 10.1159/000321965 · DOI
- Brown, 2005, Neurodegenerative diseases: an overview of environmental risk factors., Environ. Health Perspect., 113, 1250, 10.1289/ehp.7567 · DOI · Paper page
- Buerge, 2011, Lobar dementia due to extreme widening of virchow-robin spaces in one hemisphere., Case Rep. Neurol., 3, 136, 10.1159/000329267 · DOI
- Buga, 2013, Preclinical models of stroke in aged animals with or without comorbidities: role of neuroinflammation., Biogerontology, 14, 651, 10.1007/s10522-013-9465-0 · DOI
- Campbell, 2011, Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus., Clin. Ther., 33, 511, 10.1016/j.clinthera.2011.04.015 · DOI
- Cani, 2012, Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity., Gut Microbes, 3, 279, 10.4161/gmic.19625 · DOI · Paper page
- Carvalho, 2012, Metabolic alterations induced by sucrose intake and Alzheimer’s disease promote similar brain mitochondrial abnormalities., Diabetes Metab. Res. Rev., 61, 1234, 10.2337/db11-1186 · DOI
- Caviedes, 2017, Endothelial nitric oxide synthase is present in dendritic spines of neurons in primary cultures., Front. Cell Neurosci., 11, 10.3389/fncel.2017.00180 · DOI
- Chalazonitis, 2018, Enteric nervous system manifestations of neurodegenerative disease., Brain Res., 1693, 207, 10.1016/j.brainres.2018.01.011 · DOI
- Chao, 2009, Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson’s disease., J. Neuroimmunol., 216, 39, 10.1016/j.jneuroim.2009.09.003 · DOI
- Charidimou, 2014, White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?, Neurology, 82, 57, 10.1212/01.wnl.0000438225.02729.04 · DOI · Paper page
- Chen, 2010, Thrombin mediates severe neurovascular injury during ischemia., Stroke, 41, 2348, 10.1161/strokeaha.110.584920 · DOI
- Ching, 2018, Schwann cell-like differentiated adipose stem cells promote neurite outgrowth via secreted exosomes and RNA transfer., Stem Cell Res. Ther., 9, 10.1186/s13287-018-1017-8 · DOI
- Choi, 2011, Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model., Stroke, 42, 2595, 10.1161/strokeaha.111.620179 · DOI · Paper page
- Cole, 2019, Brain age and other bodily ’ages’: implications for neuropsychiatry., Mol. Psychiatry, 24, 266, 10.1038/s41380-018-0098-1 · DOI · Paper page
- Cole, 2006, Pain sensitivity and fMRI pain-related brain activity in Alzheimer’s disease., Brain, 129, 2957, 10.1093/brain/awl228 · DOI · Paper page
- Collins, 2012, Parasympathetic autonomic dysfunction is common in mild cognitive impairment., Neurobiol. Aging, 33, 2324, 10.1016/j.neurobiolaging.2011.11.017 · DOI
- Collins, 2013, Gut microbiota: intestinal bacteria influence brain activity in healthy humans., Nat. Rev. Gastroenterol. Hepatol., 10, 326, 10.1038/nrgastro.2013.76 · DOI
- Conte, 2013, Pathophysiology of somatosensory abnormalities in Parkinson disease., Nat. Rev. Neurol., 9, 687, 10.1038/nrneurol.2013.224 · DOI · Paper page
- Coon, 2018, Neuropathology of autonomic dysfunction in synucleinopathies., Mov. Disord., 33, 349, 10.1002/mds.27186 · DOI · Paper page
- Cordonnier, 2011, Brain microbleeds: more evidence, but still a clinical dilemma., Curr. Opin. Neurol., 24, 69, 10.1097/wco.0b013e328341f8c0 · DOI · Paper page
- Coulter, 2018, The ESCRT-III protein CHMP1A mediates secretion of sonic hedgehog on a distinctive subtype of extracellular vesicles., Cell Rep., 24, 973, 10.1016/j.celrep.2018.06.100 · DOI
- Crous-Bou, 2017, Alzheimer’s disease prevention: from risk factors to early intervention., Alzheimers Res. Ther., 9, 10.1186/s13195-017-0297-z · DOI · Paper page
- Dabby, 2006, Skin biopsy for assessment of autonomic denervation in Parkinson’s disease., J. Neural Transm., 113, 1169, 10.1007/s00702-005-0431-0 · DOI
- Dalle Pezze, 2014, Dynamic modelling of pathways to cellular senescence reveals strategies for targeted interventions., PLoS Comput. Biol., 10, 10.1371/journal.pcbi.1003728 · DOI · Paper page
- Davaapil, 2017, Conserved and novel functions of programmed cellular senescence during vertebrate development., Development, 144, 106, 10.1242/dev.138222 · DOI · Paper page
- Dearborn, 2017, Intracranial atherosclerosis and dementia: the atherosclerosis risk in communities (ARIC) study., Neurology, 88, 1556, 10.1212/wnl.0000000000003837 · DOI
- Dickinson, 2001, Why are strokes related to hypertension? Classic studies and hypotheses revisited., J. Hypertens., 19, 1515, 10.1097/00004872-200109000-00001 · DOI
- Dietzel, 2018, Does atrial fibrillation cause cognitive decline and dementia?, Europace, 20, 408, 10.1093/europace/eux031 · DOI
- Dirnagl, 1997, Metabolic aspects of neurovascular coupling., Adv. Exp. Med. Biol., 413, 155, 10.1007/978-1-4899-0056-2_17 · DOI
- Dobbs, 1999, Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism., Acta Neurol. Scand., 100, 34, 10.1111/j.1600-0404.1999.tb00721.x · DOI · Paper page
- Dolan, 2010, Atherosclerosis, dementia, and Alzheimer disease in the baltimore longitudinal study of aging cohort., Ann. Neurol., 68, 231, 10.1002/ana.22055 · DOI · Paper page
- Doty, 2017, Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate?, Lancet Neurol., 16, 478, 10.1016/s1474-4422(17)30123-0 · DOI · Paper page
- Driver-Dunckley, 2014, Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease., Parkinsonism Relat. Disord., 20, 1260, 10.1016/j.parkreldis.2014.08.006 · DOI
- Duarte, 2013, Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration., Biochim. Biophys. Acta, 1832, 527, 10.1016/j.bbadis.2013.01.008 · DOI
- Duarte, 2012, Insulin in central nervous system: more than just a peripheral hormone., J. Aging Res., 2012, 10.1155/2012/384017 · DOI · Paper page
- Duda, 1999, The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases., Exp. Neurol., 160, 515, 10.1006/exnr.1999.7228 · DOI
- Duran-Vilaregut, 2009, Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid., Neurotoxicology, 30, 136, 10.1016/j.neuro.2008.10.007 · DOI
- Eberle, 2012, Diabetic and metabolic programming: mechanisms altering the intrauterine milieu., ISRN Pediatr., 2012, 10.5402/2012/975685 · DOI
- Fan, 2017, Mechanisms of hippocampal aging and the potential for rejuvenation., Annu. Rev. Neurosci., 40, 251, 10.1146/annurev-neuro-072116-031357 · DOI
- Faraci, 1998, Regulation of the cerebral circulation: role of endothelium and potassium channels., Physiol. Rev., 78, 53, 10.1152/physrev.1998.78.1.53 · DOI · Paper page
- Fevrier, 2004, Cells release prions in association with exosomes., Proc. Natl. Acad. Sci. U.S.A., 101, 9683, 10.1073/pnas.0308413101 · DOI · Paper page
- Figueira, 2016, NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls., Mol. Biosyst., 12, 2562, 10.1039/c6mb00233a · DOI
- Fleitas, 2018, proBDNF is modified by advanced glycation end products in Alzheimer’s disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing., Mol. Brain, 11, 10.1186/s13041-018-0411-6 · DOI · Paper page
- Gan, 2018, Converging pathways in neurodegeneration, from genetics to mechanisms., Nat. Neurosci., 21, 1300, 10.1038/s41593-018-0237-7 · DOI · Paper page
- Gariepy, 2011, Obesity and the risk of disability in a 12-year cohort study: the role of psychological distress., Soc. Psychiatry Psychiatr. Epidemiol., 46, 1173, 10.1007/s00127-010-0284-1 · DOI
- Garner, 2017, Introducing therioepistemology: the study of how knowledge is gained from animal research., Lab Anim., 46, 103, 10.1038/laban.1224 · DOI
- Gensollen, 2016, How colonization by microbiota in early life shapes the immune system., Science, 352, 539, 10.1126/science.aad9378 · DOI · Paper page
- Girouard, 2006, Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease., J. Appl. Physiol., 100, 328, 10.1152/japplphysiol.00966.2005 · DOI · Paper page
- Gitler, 2017, Neurodegenerative disease: models, mechanisms, and a new hope., Dis. Model Mech., 10, 499, 10.1242/dmm.030205 · DOI · Paper page
- Graves, 2017, Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long-term warfarin., Am. Heart J., 188, 93, 10.1016/j.ahj.2017.02.026 · doi:10.1016/j.ahj.2017.02.026
- Grey, 2015, Acceleration of alpha-synuclein aggregation by exosomes., J. Biol. Chem., 290, 2969, 10.1074/jbc.m114.585703 · DOI · Paper page
- Grunert, 2013, Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients., Orphanet J. Rare Dis., 8, 10.1186/1750-1172-8-6 · DOI · Paper page
- Gutierrez Becker, 2018, Gaussian process uncertainty in age estimation as a measure of brain abnormality., Neuroimage, 175, 246, 10.1016/j.neuroimage.2018.03.075 · DOI
- Hallene, 2006, Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations., Neuroscience, 142, 267, 10.1016/j.neuroscience.2006.06.017 · DOI
- Helzner, 2009, Contribution of vascular risk factors to the progression in Alzheimer disease., Arch. Neurol., 66, 343, 10.1001/archneur.66.3.343 · DOI · Paper page
- Hill, 2015, Microbial-generated amyloids and Alzheimer’s disease (AD)., Front. Aging Neurosci., 7, 10.3389/fnagi.2015.00009 · DOI · Paper page
- Hofman, 1997, Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the rotterdam Study., Lancet, 349, 151, 10.1016/s0140-6736(96)09328-2 · DOI · Paper page
- Holm, 2018, Extracellular vesicles: multimodal envoys in neural maintenance and repair., Trends Neurosci., 41, 360, 10.1016/j.tins.2018.03.006 · DOI · Paper page
- Houlden, 2016, Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production., Brain Behav. Immun., 57, 10, 10.1016/j.bbi.2016.04.003 · DOI · Paper page
- Howitt, 2016, Exosomes in the pathology of neurodegenerative diseases., J. Biol. Chem., 291, 26589, 10.1074/jbc.r116.757955 · DOI · Paper page
- Hryhorczuk, 2013, Metabolic disturbances connecting obesity and depression., Front. Neurosci., 7, 10.3389/fnins.2013.00177 · DOI · Paper page
- Hsu, 2017, Primary and secondary prevention trials in Alzheimer disease: looking back, Moving Forward., Curr. Alzheimer Res., 14, 426, 10.2174/1567205013666160930112125 · DOI · Paper page
- Hufeldt, 2010, Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors., Comp. Med., 60, 336
- Iadecola, 2013, The pathobiology of vascular dementia., Neuron, 80, 844, 10.1016/j.neuron.2013.10.008 · DOI · Paper page
- Idiaquez, 2011, Autonomic dysfunction in neurodegenerative dementias., J. Neurol. Sci., 305, 22, 10.1016/j.jns.2011.02.033 · DOI
- 2002, Constitution of the World Health Organization. 1946., Bull. World Health Organ, 80, 983
- Jellinger, 2010, Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases., Neurodegener. Dis., 7, 112, 10.1159/000285518 · DOI
- Jia, 2018, Exosomes derived from high-glucose-stimulated schwann cells promote development of diabetic peripheral neuropathy., FASEB J, 10.1096/fj.201800597R · DOI
- Joachim, 1989, Amyloid beta-protein deposition in tissues other than brain in Alzheimer’s disease., Nature, 341, 226, 10.1038/341226a0 · DOI · Paper page
- Kalaria, 2010, Vascular basis for brain degeneration: faltering controls and risk factors for dementia., Nutr. Rev., S74, 10.1111/j.1753-4887.2010.00352.x · DOI · Paper page
- Kim, 2018, Distinct amyloid precursor protein processing machineries of the olfactory system., Biochem. Biophys. Res. Commun., 495, 533, 10.1016/j.bbrc.2017.10.153 · DOI
- Kim, 2016, Vasculo-neuronal coupling: retrograde vascular communication to brain neurons., J. Neurosci., 36, 12624, 10.1523/jneurosci.1300-16.2016 · DOI
- Klein, 2017, Prevention of epilepsy: should we be avoiding clinical trials?, Epilepsy Behav, 72, 188, 10.1016/j.yebeh.2017.05.024 · DOI
- Koles, 2012, Mechanism of evenness interrupted (Evi)-exosome release at synaptic boutons., J. Biol. Chem., 287, 16820, 10.1074/jbc.m112.342667 · DOI · Paper page
- Korhonen, 2018, 3D human brain cell models: new frontiers in disease understanding and drug discovery for neurodegenerative diseases., Neurochem. Int., 120, 191, 10.1016/j.neuint.2018.08.012 · DOI
- Kountouras, 2009, Eradication of helicobacter pylori may be beneficial in the management of Alzheimer’s disease., J. Neurol., 256, 758, 10.1007/s00415-009-5011-z · DOI · Paper page
- Kupsky, 1987, Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells., Neurology, 37, 1253, 10.1212/WNL.37.7.1253 · DOI · Paper page
- Lachenal, 2011, Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity., Mol. Cell. Neurosci., 46, 409, 10.1016/j.mcn.2010.11.004 · DOI · Paper page
- Larsson, 2018, Does treating vascular risk factors prevent dementia and Alzheimer’s disease? a systematic review and meta-analysis., J. Alzheimers Dis., 64, 657, 10.3233/jad-180288 · DOI · Paper page
- Lebouvier, 2009, The second brain and Parkinson’s disease., Eur. J. Neurosci., 30, 735, 10.1111/j.1460-9568.2009.06873.x · DOI · Paper page
- Lee, 2017, Medical big data: promise and challenges., Kidney Res. Clin. Pract., 36, 3, 10.23876/j.krcp.2017.36.1.3 · DOI · Paper page
- Lee, 2014, Synergistic effects of ischemia and beta-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment., JAMA Psychiatry, 71, 412, 10.1001/jamapsychiatry.2013.4506 · DOI
- Lee, 2018, Reciprocal control of excitatory synapse numbers by Wnt and Wnt inhibitor PRR7 secreted on exosomes., Nat. Commun., 9, 10.1038/s41467-018-05858-2 · DOI
- Lema Tome, 2013, Inflammation and alpha-synuclein’s prion-like behavior in Parkinson’s disease–is there a link?, Mol. Neurobiol, 47, 561, 10.1007/s12035-012-8267-8 · DOI · Paper page
- Li, 2017, Gut microbiota and atherosclerosis., Curr. Atheroscler. Rep., 19, 10.1007/s11883-017-0675-9 · DOI
- Li, 2018, In vivo evidence for the contribution of peripheral circulating inflammatory exosomes to neuroinflammation., J. Neuroinflammation, 15, 10.1186/s12974-017-1038-8 · DOI · Paper page
- Li, 1991, Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells., Cancer Res., 51, 2531
- Li, 2017, The gut microbiota and autism spectrum disorders., Front. Cell. Neurosci., 11, 10.3389/fncel.2017.00120 · DOI · Paper page
- Liddell, 2017, Are astrocytes the predominant cell type for activation of nrf2 in aging and neurodegeneration?, Antioxidants, 6, 10.3390/antiox6030065 · DOI · Paper page
- Lim, 2012, A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010., Lancet, 380, 2224, 10.1016/S0140-6736(12)61766-8 · DOI · Paper page
- Lloret-Villas, 2017, The impact of mathematical modeling in understanding the mechanisms underlying neurodegeneration: evolving dimensions and future directions., CPT Pharmacometrics Syst. Pharmacol., 6, 73, 10.1002/psp4.12155 · DOI
- Lopez-Verrilli, 2016, Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth., Neuroscience, 320, 129, 10.1016/j.neuroscience.2016.01.061 · DOI · Paper page
- Lusis, 2000, Atherosclerosis., Nature, 407, 233, 10.1038/35025203 · DOI · Paper page
- Maldonado, 2016, Lipopolysaccharide modification in Gram-negative bacteria during chronic infection., FEMS Microbiol. Rev., 40, 480, 10.1093/femsre/fuw007 · DOI · Paper page
- Manwani, 2013, Differential effects of aging and sex on stroke induced inflammation across the lifespan., Exp. Neurol., 249, 120, 10.1016/j.expneurol.2013.08.011 · DOI · Paper page
- Marin, 2018, Olfactory dysfunction in neurodegenerative diseases., Curr. Allergy Asthma Rep., 18, 10.1007/s11882-018-0796-4 · DOI · Paper page
- Mattson, 1999, Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer’s and Parkinson’s diseases., Ann. N. Y. Acad. Sci., 893, 154, 10.1111/j.1749-6632.1999.tb07824.x · DOI · Paper page
- Mergenthaler, 2004, Pathophysiology of stroke: lessons from animal models., Metab. Brain Dis., 19, 151, 10.1023/b:mebr.0000043966.46964.e6 · DOI · Paper page
- Mergenthaler, 2012, Do stroke models model stroke?, Dis Model Mech, 5, 718, 10.1242/dmm.010033 · DOI
- Mills, 2007, Biomarkers of cerebrovascular disease in dementia., Br. J. Radiol., 2, S128, 10.1259/bjr/79217686 · DOI
- Minamiyama, 2004, Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy., Hum. Mol. Genet., 13, 1183, 10.1093/hmg/ddh131 · DOI · Paper page
- Mondadori, 2006, Enhanced brain activity may precede the diagnosis of Alzheimer’s disease by 30 years., Brain, 129, 2908, 10.1093/brain/awl266 · DOI
- Moore, 2008, The hemo-neural hypothesis: on the role of blood flow in information processing., J. Neurophysiol., 99, 2035, 10.1152/jn.01366.2006 · DOI · Paper page
- Morsi, 2018, A shared comparison of diabetes mellitus and neurodegenerative disorders., J. Cell Biochem., 119, 1249, 10.1002/jcb.26261 · DOI
- Mukherjee, 2019, A microglial signature directing human aging and neurodegeneration-related gene networks., Front. Neurosci., 13, 10.3389/fnins.2019.00002 · DOI
- Nishtala, 2018, Atrial fibrillation and cognitive decline in the framingham heart study., Heart Rhythm, 15, 166, 10.1016/j.hrthm.2017.09.036 · DOI
- Nolano, 2008, Sensory deficit in Parkinson’s disease: evidence of a cutaneous denervation., Brain, 131, 1903, 10.1093/brain/awn102 · DOI · Paper page
- Olsson, 2016, CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis., Lancet Neurol., 15, 673, 10.1016/s1474-4422(16)00070-3 · DOI · Paper page
- Olufadi, 2008, Clinical and laboratory diagnosis of the metabolic syndrome., J. Clin. Pathol., 61, 697, 10.1136/jcp.2007.048363 · DOI · Paper page
- Oost, 2018, Targeting senescence to delay progression of multiple sclerosis., J. Mol. Med., 96, 1153, 10.1007/s00109-018-1686-x · DOI
- Org, 2017, Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort., Genome Biol., 18, 10.1186/s13059-017-1194-2 · DOI · Paper page
- Orimo, 2005, Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2., Mov. Disord., 20, 1350, 10.1002/mds.20594 · DOI
- Orock, 2019, Age-related cognitive impairment: role of reduced synaptobrevin-2 levels in memory and synaptic plasticity deficits., J. Gerontol. A Biol. Sci. Med. Sci., 10.1093/gerona/glz013 · DOI
- Ozkor, 2011, Endothelium-derived hyperpolarizing factor and vascular function., Cardiol. Res. Pract., 2011, 10.4061/2011/156146 · DOI
- Park, 2017, Metagenome analysis of bodily microbiota in a mouse model of Alzheimer disease using bacteria-derived membrane vesicles in blood., Exp. Neurobiol., 26, 369, 10.5607/en.2017.26.6.369 · DOI
- Pellegrinelli, 2018, Adipocyte-secreted BMP8b mediates adrenergic-induced remodeling of the neuro-vascular network in adipose tissue., Nat. Commun., 9, 10.1038/s41467-018-07453-x · DOI
- Percie du Sert, 2017, The improve guidelines (Ischaemia models: procedural refinements of in vivo experiments)., J. Cereb. Blood Flow Metab., 37, 3488, 10.1177/0271678x17709185 · DOI · Paper page
- Petcu, 2008, Cellular and molecular events underlying the dysregulated response of the aged brain to stroke: a mini-review., Gerontology, 54, 6, 10.1159/000112845 · DOI
- Poels, 2012, Arterial stiffness and cerebral small vessel disease: the rotterdam scan study., Stroke, 43, 2637, 10.1161/strokeaha.111.642264 · DOI · Paper page
- Polanco, 2016, Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold-dependent manner., J. Biol. Chem., 291, 12445, 10.1074/jbc.m115.709485 · DOI · Paper page
- Popa-Wagner, 2011, Perturbed cellular response to brain injury during aging., Ageing Res. Rev., 10, 71, 10.1016/j.arr.2009.10.008 · DOI
- Popa-Wagner, 2007, The response of the aged brain to stroke: too much, too soon?, Curr. Neurovasc. Res, 4, 216, 10.2174/156720207781387213 · DOI
- Popa-Wagner, 2010, Pathophysiology of the vascular wall and its relevance for cerebrovascular disorders in aged rodents., Curr. Neurovasc. Res., 7, 251, 10.2174/156720210792231813 · DOI
- Postuma, 2015, REM sleep behavior disorder and neuropathology in Parkinson’s disease., Mov. Disord., 30, 1413, 10.1002/mds.26347 · DOI · Paper page
- Przedborski, 2003, Neurodegeneration: what is it and where are we?, J. Clin. Invest., 111, 3, 10.1172/JCI200317522 · DOI · Paper page
- Purves, 1988, Body and Brain: A Trophic Theory of Neural Connections.
- Qureshi, 2013, Towards a ’systems’-level understanding of the nervous system and its disorders., Trends Neurosci., 36, 674, 10.1016/j.tins.2013.07.003 · DOI
- Racosta, 2015, Autonomic dysfunction in multiple sclerosis., Auton. Neurosci., 193, 1, 10.1016/j.autneu.2015.06.001 · DOI
- Ramirez, 2015, Visible virchow-robin spaces on magnetic resonance imaging of Alzheimer’s disease patients and normal elderly from the sunnybrook dementia study., J. Alzheimers. Dis., 43, 415, 10.3233/jad-132528 · DOI · Paper page
- Ransohoff, 2018, All (animal) models (of neurodegeneration) are wrong. Are they also useful?, J. Exp. Med., 215, 2955, 10.1084/jem.20182042 · DOI · Paper page
- Reichling, 2011, Pain and death: neurodegenerative disease mechanisms in the nociceptor., Ann. Neurol., 69, 13, 10.1002/ana.22351 · DOI
- Rios-Covian, 2016, Intestinal short chain fatty acids and their link with diet and human health., Front. Microbiol., 7, 10.3389/fmicb.2016.00185 · DOI · Paper page
- Ritzel, 2018, Aging alters the immunological response to ischemic stroke., Acta Neuropathol., 136, 89, 10.1007/s00401-018-1859-2 · DOI · Paper page
- Robbins, 2017, Human induced pluripotent stem cells as a research tool in Alzheimer’s disease., Psychol. Med., 47, 2587, 10.1017/s0033291717002124 · DOI
- Roberts, 2018, The human brain microbiome; there are bacteria in our brains!, Conference Report at the Society for Neuroscience Meeting
- Rogers, 1984, Senescent microstructural changes in rat cerebellum., Brain Res., 292, 23, 10.1016/0006-8993(84)90886-2 · DOI
- Roquer, 2009, Endothelial dysfunction, vascular disease and stroke: the ARTICO study., Cerebrovasc. Dis., 25, 10.1159/000200439 · DOI
- Roriz-Filho, 2009, (Pre)diabetes, brain aging, and cognition., Biochim. Biophys. Acta, 1792, 432, 10.1016/j.bbadis.2008.12.003 · DOI · Paper page
- Roy, 1890, On the regulation of the blood-supply of the brain., J. Physiol., 11, 85, 10.1113/jphysiol.1890.sp000321 · DOI · Paper page
- Ryden, 2019, Atrial fibrillation increases the risk of dementia amongst older adults even in the absence of stroke., J. Intern. Med., 286, 101, 10.1111/joim.12902 · DOI
- Sadoshima, 1983, Mechanisms of protection against stroke in stroke-prone spontaneously hypertensive rats., Am. J. Physiol., 244, H406
- Saha, 2000, Induction of neuronal death by alpha-synuclein., Eur. J. Neurosci., 12, 3073, 10.1046/j.1460-9568.2000.00210.x · DOI · Paper page
- Sanchez-Tapia, 2017, Nopal (Opuntia ficus indica) protects from metabolic endotoxemia by modifying gut microbiota in obese rats fed high fat/sucrose diet., Sci. Rep., 7, 10.1038/s41598-017-05096-4 · DOI
- Sanguinetti, 2018, Microbiome-metabolome signatures in mice genetically prone to develop dementia, fed a normal or fatty diet., Sci. Rep., 8, 10.1038/s41598-018-23261-1 · DOI
- Schmidt, 1994, NO at work., Cell, 78, 919, 10.1016/0092-8674(94)90267-4 · DOI · Paper page
- Seib, 2015, Neurogenesis in the normal ageing hippocampus: a mini-review., Gerontology, 61, 327, 10.1159/000368575 · DOI
- Selvarajah, 2009, Potential surrogate markers of cerebral microvascular angiopathy in asymptomatic subjects at risk of stroke., Eur. Radiol., 19, 1011, 10.1007/s00330-008-1202-8 · DOI
- Shankle, 1993, Studies of the enteric nervous system in Alzheimer disease and other dementias of the elderly: enteric neurons in Alzheimer disease., Mod. Pathol., 6, 10
- Shen, 2017, Alzheimer’s disease histological and behavioral manifestations in transgenic mice correlate with specific gut microbiome state., J. Alzheimers. Dis., 56, 385, 10.3233/jad-160884 · DOI · Paper page
- Shiue, 2019, Mesenchymal stem cell exosomes as a cell-free therapy for nerve injury-induced pain in rats., Pain, 160, 210, 10.1097/j.pain.0000000000001395 · DOI · Paper page
- Silvestrini, 2006, Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease., Stroke, 37, 1010, 10.1161/01.str.0000206439.62025.97 · DOI · Paper page
- Simeoli, 2017, Exosomal cargo including microRNA regulates sensory neuron to macrophage communication after nerve trauma., Nat. Commun., 8, 10.1038/s41467-017-01841-5 · DOI · Paper page
- Singh, 2016, Microbiota dysbiosis controls the neuroinflammatory response after stroke., J. Neurosci., 36, 7428, 10.1523/jneurosci.1114-16.2016 · DOI · Paper page
- Singh, 2018, The gut microbiome primes a cerebroprotective immune response after stroke., J. Cereb. Blood Flow Metab., 38, 1293, 10.1177/0271678x18780130 · DOI · Paper page
- Smith, 1999, Altered brain activation in cognitively intact individuals at high risk for Alzheimer’s disease., Neurology, 53, 1391, 10.1212/WNL.53.7.1391 · DOI · Paper page
- Snowdon, 1997, Brain infarction and the clinical expression of Alzheimer disease. The nun study., JAMA, 277, 813, 10.1001/jama.277.10.813 · doi:10.1001/jama.277.10.813 · Paper page
- Song, 2007, Clinical significance of silent cerebral infarctions in patients with Alzheimer disease., Cogn. Behav. Neurol., 20, 93, 10.1097/wnn.0b013e31805d859e · DOI
- Stanley, 2018, An insight into intestinal mucosal microbiota disruption after stroke., Sci. Rep., 8, 10.1038/s41598-017-18904-8 · DOI · Paper page
- Syeda, 2018, Bioactive food abates metabolic and synaptic alterations by modulation of gut microbiota in a mouse model of Alzheimer’s disease., J. Alzheimers. Dis., 66, 1657, 10.3233/jad-180556 · DOI · Paper page
- Szablewski, 2018, Human gut microbiota in health and Alzheimer’s disease., J. Alzheimers. Dis., 62, 549, 10.3233/jad-170908 · DOI
- Taguchi, 2016, Brain region-dependent differential expression of alpha-synuclein., J. Comp. Neurol., 524, 1236, 10.1002/cne.23901 · DOI · Paper page
- Thery, 2018, Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines., J. Extracell. Vesicles, 7, 10.1080/20013078.2018.1535750 · DOI · Paper page
- Tian, 2014, Endothelial cell senescence and age-related vascular diseases., J. Genet. Genom., 41, 485, 10.1016/j.jgg.2014.08.001 · DOI
- Toledo, 2013, Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the national Alzheimer’s coordinating centre., Brain, 136, 2697, 10.1093/brain/awt188 · DOI · Paper page
- Torres-Fuentes, 2017, The microbiota-gut-brain axis in obesity., Lancet Gastroenterol. Hepatol., 2, 747, 10.1016/S2468-1253(17)30147-4 · DOI · Paper page
- Turnquist, 2016, p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration., Cell Death. Differ., 23, 1515, 10.1038/cdd.2016.37 · DOI · Paper page
- van Oijen, 2007, Atherosclerosis and risk for dementia., Ann. Neurol., 61, 403, 10.1002/ana.21073 · DOI · Paper page
- VanGuilder, 2010, Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome., J. Neurochem., 113, 1577, 10.1111/j.1471-4159.2010.06719.x · DOI
- Verdu, 2015, Novel players in coeliac disease pathogenesis: role of the gut microbiota., Nat. Rev. Gastroenterol. Hepatol., 12, 497, 10.1038/nrgastro.2015.90 · DOI · Paper page
- Vicente Miranda, 2016, Glycation in Parkinson’s disease and Alzheimer’s disease., Mov. Disord., 31, 782, 10.1002/mds.26566 · DOI
- Villaran, 2010, Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson‘s disease., J. Neurochem., 114, 1687, 10.1111/j.1471-4159.2010.06879.x · DOI · Paper page
- Villringer, 1997, Understanding functional neuroimaging methods based on neurovascular coupling., Adv. Exp. Med. Biol., 413, 177, 10.1007/978-1-4899-0056-2_20 · DOI
- Wakabayashi, 2010, Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain., Acta Neuropathol., 120, 1, 10.1007/s00401-010-0706-x · DOI · Paper page
- Wakabayashi, 1990, Parkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system., Acta Neuropathol., 79, 581, 10.1007/bf00294234 · DOI · Paper page
- Walsh, 2002, Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo., Nature, 416, 535, 10.1038/416535a · DOI · Paper page
- Walton, 2019, Unknown fates of (brain) oxidation or UFO: close encounters with neuronal senescence., Free Radic Biol. Med., 134, 695, 10.1016/j.freeradbiomed.2019.01.012 · DOI
- Wang, 2012, Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder., Dig. Dis. Sci., 57, 2096, 10.1007/s10620-012-2167-7 · DOI · Paper page
- Wang, 2007, Changes in hippocampal synapses and learning-memory abilities in age-increasing rats and effects of tetrahydroxystilbene glucoside in aged rats., Neuroscience, 149, 739, 10.1016/j.neuroscience.2007.07.065 · DOI
- Wang, 2010, Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-beta oligomerization in rats., J. Alzheimers Dis., 21, 813, 10.3233/jad-2010-100216 · DOI
- Wardlaw, 2013, Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration., Lancet Neurol., 12, 822, 10.1016/S1474-4422(13)70124-8 · DOI · Paper page
- Wendell, 2012, Carotid atherosclerosis and prospective risk of dementia., Stroke, 43, 3319, 10.1161/strokeaha.112.672527 · DOI · Paper page
- Wenk, 2000, Regional changes in the hippocampal density of AMPA and NMDA receptors across the lifespan of the rat., Brain Res., 885, 1, 10.1016/s0006-8993(00)02792-x · DOI
200 of 213 shown
Cited by
Cano, A., Sánchez-López, E., Ettcheto, M., López-Machado, A., Espina, M., Souto, E. B., Galindo, R., Camins, A., García, M. L., & Turowski, P. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0443 · Cited by 144
Jia, W., Rajani, C., Kaddurah‐Daouk, R., & Li, H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21653 · Cited by 88
“Nevertheless, it should be noted that strong variations have been observed in terms of the relationship between gut microbial diversity and AD either in patients or mice models, which is extensively reviewed by Castillo et al recently.(40) There are many variables that may exert dramatic impacts on the consistency of…”
BackgroundLiu, X., Shen, L., Wan, M., Xie, H., & Wang, Z. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02428-1 · Cited by 33
“…between the peripheral environment and the brain is emerging as a significant factor in the etio-pathogenesis of NDDs. Peripheral cells have been shown to secrete exogenous toxic protein species that can spread to the CNS, potentially instigating or exacerbating neurodegenerative cascades [14].”
Background
Metadata
- Authors
- Castillo, X., Castro-Obregón, S., Gutiérrez-Becker, B., Gutiérrez-Ospina, G., Karalis, N., Khalil, A. A., Lopez-Noguerola, J. S., Rodríguez, L. L., Martínez-Martínez, E., Perez-Cruz, C., Pérez-Velázquez, J., Piña, A. L., Rubio, K., García, H. P. S., Syeda, T., Vanoye-Carlo, A., Villringer, A., Winek, K., & Zille, M.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-07-24
- Volume
- 13
- Pages
- 728-728
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2963701142
- Cited by
- 79
- References
- 122
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Bundesministerium für Bildung und Forschung
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Re-thinking the Etiological Framework of Neurodegeneration. https://app.cochat.ai/papers/10.3389/fnins.2019.00728
- The paper
- Castillo, X., Castro-Obregón, S., Gutiérrez-Becker, B., Gutiérrez-Ospina, G., Karalis, N., Khalil, A. A., Lopez-Noguerola, J. S., Rodríguez, L. L., Martínez-Martínez, E., Perez-Cruz, C., Pérez-Velázquez, J., Piña, A. L., Rubio, K., García, H. P. S., Syeda, T., Vanoye-Carlo, A., Villringer, A., Winek, K., & Zille, M. (2019). Re-thinking the Etiological Framework of Neurodegeneration. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2019.00728
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.